HER2, EGFR, PIK3CA mutations in HER2+ metastatic breast cancer (MBC) patients (pts) treated with trastuzumab (T): Incidence and correlation with response

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 26; no. 15_suppl; p. 1031
Main Authors	Gori, S., Ludovini, V., Colozza, M., Pistola, L., Tofanetti, F. R., Flacco, A., Foglietta, J., Minenza, E., Stocchi, L., De Angelis, V., Crinò, L.
Format	Journal Article
Language	English
Published	20.05.2008
Online Access	Get full text

Loading…